- Home
- Labeler Index
- Gilead Sciences, Inc.
- 61958-2203
- NDC Crossover: 61958-2203 Epclusa
NDC Crossover 61958-2203 Epclusa
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Sofosbuvir; Velpatasvir
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 61958-2203 – Epclusa, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Epclusa
- OR Generic name: Velpatasvir And Sofosbuvir
- AND the same Administration Route: oral
- OR Dosage Form: tablet, film coated
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
61958-2201 | Epclusa | Velpatasvir And Sofosbuvir | Tablet, Film Coated | Oral | Gilead Sciences, Inc. | Human Prescription Drug |
61958-2204 | Epclusa | Velpatasvir And Sofosbuvir | Pellet | Oral | Gilead Sciences, Inc. | Human Prescription Drug |
61958-2205 | Epclusa | Velpatasvir And Sofosbuvir | Pellet | Oral | Gilead Sciences, Inc. | Human Prescription Drug |
72626-2701 | Sofosbuvir And Velpatasvir | Velpatasvir And Sofosbuvir | Tablet, Film Coated | Oral | Asegua Therapeutics Llc | Human Prescription Drug |